Found: 2
Select item for more details and to access through your institution.
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 1, p. 127, doi. 10.1007/s10549-017-4518-8
- By:
- Publication type:
- Article
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 659, doi. 10.1007/s10549-017-4523-y
- By:
- Publication type:
- Article